BOTHELL, WA, April 29, 2019 /PRNewswire/ -- BTG plc (LSE: BTG), the global specialist healthcare company, today highlighted the VIEW VLU Registry interim study results, presented at the International ...
BTG plc: FDA approves Varithena™ (polidocanol injectable foam) for the treatment of patients with varicose veins London, UK, 26 November 2013: BTG plc (LSE: BTG), the specialist healthcare company, ...
BTG plc (LSE: BTG), the specialist healthcare company, today announces that the US Food and Drug Administration (FDA) has approved Varithena(TM) (polidocanol injectable foam) for the treatment of ...
WORTHINGTON, OH, UNITED STATES, June 9, 2026 /EINPresswire.com/ — Akribis Veins & Vitality is educating patients about today’s leading minimally invasive varicose ...
FREDERICKSBURG, Texas, Jan. 14, 2020 /PRNewswire-PRWeb/ -- Varicose vein treatment is the latest addition to the medical offerings from board-certified specialist, Robin Fleck, MD, founder and medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results